| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.4M | -57.9% | -5.0% |
| Cost of Revenue | $10.1M | -22.7% | +51.9% |
| Gross Profit | -$7.7M | -4.4% | -86.5% |
| R&D Expense | $1.1M | -13.5% | -53.4% |
| SG&A Expense | $7.8M | +33.0% | +0.6% |
| Operating Income | -$16.6M | -14.4% | -16.9% |
| Pre-tax Income | -$7.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $12.7M | +480.9% | +292.2% |
| Accounts Receivable | $1.2M | -51.4% | +68.7% |
| Inventory | $30.0M | -8.4% | -30.5% |
| Current Assets | $73.0M | +14.6% | +26.9% |
| Total Assets | $116.7M | +17.6% | +15.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$25.0M | — | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $19.5M | — | — |
| Financing Cash Flow | $39.1M | — | — |
| Free Cash Flow | -$25.0M | — | — |
| +47.0% |
| +68.9% |
| Income Tax | $0 | — | — |
| Net Income | -$7.8M | +47.0% | +68.9% |
| EPS (Basic) | -$0.50 | +70.1% | +49.0% |
| EPS (Diluted) | -$0.50 | +70.1% | +49.0% |
| $60.4M |
| -17.8% |
| +21.8% |
| Total Liabilities | $84.7M | +10.1% | +56.3% |
| Stockholders' Equity | $32.1M | +43.5% | -32.1% |